NCT03293706已完成不适用
Evaluation of Carbohydrates (CHO): Tolerance, Breath Hydrogen and Methane
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 13
- 试验地点
- 2
- 主要终点
- Breath hydrogen
研究概览
简要总结
The study is single-blind with a randomized, cross-over design to evaluate gastrointestinal tolerance of carbohydrate blends.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Other
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Males or non-pregnant females in good health.
- •Eligible to receive income in Canada and must demonstrate OHIP or equivalent medical coverage.
排除标准
- •Subject with any type of food allergy or with a known history of AIDS, hepatitis, diabetes, cardio-vascular disease or GI disease.
- •Subject taking medication, or with any condition which might, in the opinion of the PI either make participation dangerous to the subject or to others or affect the results.
研究组 & 干预措施
CHO Control 1 Glucose
Active Comparator
25 g glucose
干预措施: CHO Control 1 and 2 Glucose (Other)
CHO Control 2 Glucose
Active Comparator
25 g glucose
干预措施: CHO Control 1 and 2 Glucose (Other)
CHO Experimental 1 Slowly Digested
Experimental
25 g slowly-digested carbohydrate blend
干预措施: CHO Experimental 1 Slowly Digested (Other)
CHO Experimental 2 Digestion Resistant
Experimental
25 g digestion-resistant carbohydrate blend
干预措施: CHO Experimental 2 Digestion Resistant (Other)
CHO Experimental 3 Low Sugar
Experimental
25 g low sugar carbohydrate blend
干预措施: CHO Experimental 3 Low Sugar (Other)
CHO Experimental 4 Maltodextrin
Experimental
25 g maltodextrin
干预措施: CHO Experimental 4 Maltodextrin (Other)
结局指标
主要结局
Breath hydrogen
时间窗: 0 to 7 hours
Assessed in exhaled gasses
次要结局
- GI tolerance symptoms(0 to 48 hours)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Study to Evaluate the Tolerability of Prebiotics on the MicrobiotaHealthyNCT02628652Kaleido Biosciences45
招募中
不适用
Acceptability and Tolerance Study of a Plant-based Tube FeedNutrition DisordersNCT06209593Société des Produits Nestlé (SPN)15
已完成
不适用
Acute Gastrointestinal Tolerability Following a Single Serving of a Novel Dietary FiberSigns and Symptoms, DigestiveNCT02530762Cargill45
已完成
不适用
Gastrointestinal Tolerability Following Multiple Servings of a Novel Dietary FiberSigns and Symptoms, DigestiveNCT02532985Cargill45
已完成
3 期
Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)OsteoarthritisNCT00092703Organon and Co6,000